ASID supports ATAGI statement recommending birth-born Hep B vaccination

“ASID members stand with ATAGI on the importance and safety of hepatitis B vaccination at birth. The science is clear and our experts agree: giving the first dose within 24 hours of birth is a safe, effective and critical measure to prevent hepatitis B transmission and protect infants from lifelong chronic infection, liver disease and cancer. This evidence-based recommendation reflects decades of research and real-world experience, and ASID strongly supports ensuring all eligible newborns receive the hepatitis B birth dose as recommended.”